MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    An automated AI-based framework for putamen volume measurement in MSA

    M. Papoutsi, J. Weatheritt, M. Reinwald, I. Gidado, R. Joules, H. Kaufmann, I. Qureshi, R. Wolz (London, United Kingdom)

    Objective: The putamen is a difficult structure to segment accurately, and automated methods require manual editing to improve segmentation accuracy. Our aim was to test…
  • 2022 International Congress

    Biomarker based on natural language processing methods to detect the stages of Parkinson’s disease through electroencephalography

    A. Maitin, J. Morales, S. Romero-Azpitarte, J. Romero, A. Arroyo Ferrer, Y. González Zamorano, F. Sánchez Cuesta, A. García-Tejedor (Pozuelo de Alarcón, Spain)

    Objective: Stage classification of Parkinson's Disease (PD) through Electroencephalograms (EEGs) using Natural Language Processing (NLP) techniques. Background: PD is a neurodegenerative disease mainly characterized by…
  • 2022 International Congress

    The effects of converting to Dysport from other botulinum toxin type A formulations for treating cervical dystonia patients

    O. Samotus, M. Jog (London, Canada)

    Objective: To investigate whether Dysport increases waning time compared to other botulinum toxin type A (BoNT-A) formulations for cervical dystonia (CD) therapy. Background: BoNT-A injections…
  • 2022 International Congress

    Milder presentation in two compound heterozygote cases of spastic paraplegias type 5

    A. Zolin, S. Lakhani, H. Sarva (New York, USA)

    Objective: Describing two mild compound heterozygote SPG5A cases. Background: Hereditary spastic paraplegia type 5 (SPG5A) is an autosomal recessive neurodegenerative disease caused by variants in…
  • 2022 International Congress

    Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study

    C. Liguori, C. de Masi, M. Spanetta, M. Fernandes, R. Cerroni, E. Garasto, M. Pierantozzi, N. Mercuri, A. Stefani (Rome, Italy)

    Objective: The present study aimed to explore the effect of safinamide treatment on NMS and quality of life in motor-fluctuating PD patients. Background: Parkinson’s disease…
  • 2022 International Congress

    A systematic review on physical health education interventions for people with Parkinson’s: content, impact and implementation considerations across Parkinson’s trajectory

    L. Alushi, J. Alexander, J. Jones (Cambridge, United Kingdom)

    Objective: To examine the content of education interventions that promote physical activity (PA) behavior in PwP, and to assess their effectiveness on physical and psychosocial…
  • 2022 International Congress

    The Effect of a Boxing Exercise Program on Laryngeal Function in People with Parkinson’s Disease

    Z. Thijs, C. Watts (Fort Worth, USA)

    Objective: This project aimed to determine the effect of a boxing exercise program on aerodynamic measures related to voice production (maximum expiratory pressure, MEP; transglottal…
  • 2022 International Congress

    Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

    L. Hickman, D. Fraser, J. Galea, J. Cook (Birmingham, United Kingdom)

    Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…
  • 2022 International Congress

    Short and long-term cental action of botulinum neurotoxin treatment in laryngeal dystonia

    L. O'Flynn, K. Simonyan (Boston, USA)

    Objective: To investigate short- and long-term central effects of BoNT treatment on brain function in patients with laryngeal dystonia (LD). Background: LD is an isolated…
  • 2022 International Congress

    Parkinson’s Progression Marker Initiative (PPMI) Online identifies people with features of prodromal Parkinson’s Disease through online questionnaires

    E. Brown, L. Chahine, D. Alonso, C. Coffey, R. Dobkin, T. Foroud, M. Korell, A. Lorenzo, C. Marras, W. Poewe, T. Sherer, A. Siderowf, T. Simuni, E. Tolosa, J. Valverde Twiggs, D. Weintraub, S. Chowdhury, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To implement staged screening to identify people with features of prodromal Parkinson’s disease (PD). Background: The subtle motor and non-motor symptoms that occur prior…
  • « Previous Page
  • 1
  • …
  • 512
  • 513
  • 514
  • 515
  • 516
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley